BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough breast cancer: drug aims to boost immune attack
Disease control TerminatedThis study tested the drug abemaciclib in 26 women with triple negative breast cancer that did not respond to standard chemotherapy. The goal was to see if the drug could increase immune cell activity in the tumor before surgery. The trial was stopped early, but results may help …
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 06:11 UTC
-
Tamoxifen gel vs. pill: a gentler way to prevent breast cancer?
Prevention TerminatedThis study tested whether a tamoxifen gel applied to the skin could work as well as the pill form to lower breast cancer risk in women with certain high-risk breast conditions. About 65 women with atypical hyperplasia or lobular carcinoma in situ were planned to take part. The tr…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated May 22, 2026 13:54 UTC
-
Genetic risk tool tested to improve breast cancer decisions in minority women
Knowledge-focused TerminatedThis study looked at whether adding a genetic risk score to standard breast cancer risk tools helps African American and Hispanic women decide on extra screening or prevention. About 19 women took part. The goal was to see if personalized genetic information improves understandin…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 06:08 UTC